tradingkey.logo
tradingkey.logo
Search

Maze Therapeutics Inc

MAZE
Add to Watchlist
24.580USD
-1.790-6.79%
Close 09-09 16:00ET
1.37BMarket Cap
LossP/E TTM

MAZE Financials

See Maze Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
1.37B
Dividend TTM
0.00
P/E TTM
-10.45
EPS TTM
-2.35
Revenue
0.00
Net Profit
3.40M
ROE
-38.67%
ROA
-32.57%

Maze Therapeutics Inc Earnings Date

Latest Release
Aug 11, 2026
EPS / Forecast
-0.76/-0.73
Revenue / Forecast
0.00/2.00M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
Financial Indicators
EPS
1.41%-0.76
60.78%-0.45
-476.43%-0.65
-1085.44%-0.66
---0.77
---1.15
81.54%-0.11
90.19%-0.06
----
----
---0.61
---0.57
----
----
----
Revenue
--0.00
--20.00M
--0.00
-100.00%0.00
--0.00
----
--0.00
--2.50M
----
----
----
--0.00
----
----
----
Net Profit
-32.80%-44.73M
26.16%-24.21M
-604.61%-34.57M
-1139.68%-30.09M
---33.68M
---32.79M
81.54%-4.91M
90.19%-2.43M
----
----
---26.58M
---24.75M
----
----
----
Net Margin
----
---121.04%
----
----
----
----
----
---97.08%
----
----
----
----
----
----
----
Gross Margin
----
--100.00%
----
----
----
----
----
--100.00%
----
----
----
----
----
----
----
Debt to assets ratio
--7.33%
--9.25%
----
----
----
----
--0.00%
--26.88%
--22.75%
----
----
----
----
----
----
Revenue
--0.00
--20.00M
--0.00
-100.00%0.00
--0.00
----
--0.00
--2.50M
----
----
----
--0.00
----
----
----
Operating profit
-31.70%-48.03M
24.99%-26.55M
-28.03%-38.06M
-36.06%-32.97M
---36.47M
---35.40M
-28.96%-29.73M
3.96%-24.23M
----
----
---23.05M
---25.23M
----
----
----
Net Profit
-32.80%-44.73M
26.16%-24.21M
-604.61%-34.57M
-1139.68%-30.09M
---33.68M
---32.79M
81.54%-4.91M
90.19%-2.43M
----
----
---26.58M
---24.75M
----
----
----
Current assets
55.05%420.42M
26.72%379.78M
73.41%349.72M
154.16%391.30M
51.14%271.15M
--299.71M
--201.67M
--153.96M
--179.40M
----
----
----
----
----
----
Total current liabilities
15.38%22.96M
14.07%21.24M
9.11%22.56M
25.96%22.11M
-7.89%19.90M
--18.62M
--20.67M
--17.55M
--21.61M
----
----
----
----
----
----
Total assets
75.15%531.63M
26.10%419.71M
65.10%397.13M
119.27%422.06M
40.65%303.52M
--332.84M
--240.54M
--192.48M
--215.79M
----
----
----
----
----
----
Total liabilities
90.16%78.50M
91.33%78.01M
-3.38%42.16M
-54.22%42.62M
-56.21%41.28M
--40.77M
--43.64M
--93.11M
--94.27M
----
----
----
----
----
----
Total equity
72.79%453.12M
16.99%341.70M
80.27%354.97M
281.84%379.44M
115.78%262.24M
--292.07M
--196.90M
--99.37M
--121.53M
----
----
----
----
----
----
Net operating income
49.91%-15.05M
-32.51%-39.11M
-23.51%-27.73M
-6.19%-24.64M
---30.05M
---29.52M
-8.76%-22.45M
-16.19%-23.20M
----
----
---20.64M
---19.97M
----
----
----
Net investment
-32598.73%-128.51M
2198.66%6.28M
-16988.76%-103.39M
-64834.95%-66.88M
---393.00K
---299.00K
-1679.41%-605.00K
-3533.33%-103.00K
----
----
---34.00K
--3.00K
----
----
----
Net financing
23990.85%147.44M
-66.75%42.36M
-94.89%3.59M
6786.37%143.76M
--612.00K
--127.38M
334.04%70.26M
-26975.00%-2.15M
----
----
--16.19M
--8.00K
----
----
----

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What are the current assets of Maze Therapeutics Inc?

According to Maze Therapeutics Inc's FY2025 earnings report, its current assets were 349.72M, with a year-on-year change of 73.41.

What are the total assets of Maze Therapeutics Inc?

According to Maze Therapeutics Inc's FY2025 earnings report, its total assets of Maze Therapeutics Inc were 397.13M, with a year-on-year change of 65.10.

What are the total liabilities of Maze Therapeutics Inc?

According to Maze Therapeutics Inc's FY2025 earnings report, its total liabilities of Maze Therapeutics Inc were 42.16M, with a year-on-year change of -3.38.

What is the total equity of Maze Therapeutics Inc?

According to Maze Therapeutics Inc's FY2025 earnings report, its total equity of Maze Therapeutics Inc was 354.97M, with a year-on-year change of 80.27.

What is the net operating income of Maze Therapeutics Inc?

According to Maze Therapeutics Inc's FY2025 earnings report, its net operating income of Maze Therapeutics Inc was -142.90M, with a year-on-year change of -348.15.

What is the net investment of Maze Therapeutics Inc?

According to Maze Therapeutics Inc's FY2025 earnings report, its net investment of Maze Therapeutics Inc was -170.96M, with a year-on-year change of -14805.14.

What is the net financing of Maze Therapeutics Inc?

According to Maze Therapeutics Inc's FY2025 earnings report, its net financing of Maze Therapeutics Inc was 275.34M, with a year-on-year change of 196.55.

What is the Earnings Per Share (EPS) of Maze Therapeutics Inc?

According to Maze Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.05, with a year-on-year change of -4022.60.

What is the net income of Maze Therapeutics Inc?

According to Maze Therapeutics Inc's FY2025 earnings report, its net income was -131.12M, with a year-on-year change of -3950.81.

What is the Return on Assets (ROA) of Maze Therapeutics Inc?

According to Maze Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -41.12, with a year-on-year change of -449.15.

What is the operating profit of Maze Therapeutics Inc?

According to Maze Therapeutics Inc's FY2025 earnings report, its operating profit was -142.90M, with a year-on-year change of -348.15.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.